Massimiliano Di Filippo Selected Research

Fingolimod Hydrochloride (FTY720)

11/2022

Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimiliano Di Filippo Research Topics

Disease

31	Multiple Sclerosis 04/2024 - 08/2007
17	Parkinson Disease (Parkinson's Disease) 01/2023 - 11/2006
7	Cognitive Dysfunction 01/2023 - 11/2006
6	Ischemia 01/2020 - 05/2006
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 02/2014
5	Inflammation (Inflammations) 01/2021 - 08/2008
4	Seizures (Absence Seizure) 02/2024 - 05/2009
4	Amyloidosis 04/2023 - 12/2016
3	Dementia (Dementias) 01/2023 - 11/2006
3	Parkinsonian Disorders (Parkinsonism) 01/2023 - 02/2008
3	Relapsing-Remitting Multiple Sclerosis 08/2021 - 08/2007
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2015
3	Nervous System Diseases (Neurological Disorders) 11/2019 - 08/2008
3	Epilepsy (Aura) 12/2016 - 05/2009
3	Brain Ischemia (Cerebral Ischemia) 02/2013 - 05/2007
3	Dyskinesias (Dyskinesia) 02/2011 - 01/2008
2	Tauopathies 04/2023 - 01/2021
2	Infections 11/2022 - 06/2022
2	Neuroinflammatory Diseases 01/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2018
2	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 04/2008
2	Stroke (Strokes) 06/2014 - 09/2008
2	Migraine Disorders (Migraine) 11/2012 - 10/2007
2	Infarction (Infarctions) 09/2008 - 05/2007
1	Lymphopenia (Lymphocytopenia) 03/2024
1	Chronic Progressive Multiple Sclerosis 01/2023
1	COVID-19 11/2022
1	Breakthrough Infections 11/2022
1	Myelitis 12/2021
1	Psoriatic Arthritis 12/2021
1	Rare Diseases (Rare Disease) 04/2020
1	Glioma (Gliomas) 11/2019
1	Memory Disorders (Memory Loss) 11/2019
1	Encephalitis (Encephalitis, Rasmussen) 11/2019
1	Movement Disorders (Movement Disorder) 11/2019

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2019
9	Dopamine (Intropin)FDA LinkGeneric 12/2016 - 11/2006
6	PlasticsIBA 10/2018 - 02/2007
5	Neuroprotective AgentsIBA 01/2020 - 05/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2006
5	Oxygen (Dioxygen)IBA 01/2020 - 05/2006
4	COVID-19 VaccinesIBA 11/2023 - 01/2022
4	Glutamic Acid (Glutamate)FDA Link 01/2023 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
4	Levodopa (L Dopa)FDA LinkGeneric 06/2012 - 01/2008
3	Oligoclonal BandsIBA 12/2023 - 01/2020
3	Leucine (L-Leucine)FDA Link 01/2023 - 10/2018
3	Glutamate Receptors (Glutamate Receptor)IBA 01/2023 - 01/2008
3	SynucleinsIBA 01/2020 - 03/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 02/2011
3	N-Methylaspartate (NMDA)IBA 01/2015 - 01/2008
2	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 01/2020
2	Excitatory Amino AcidsIBA 01/2023 - 10/2007
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2023 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2018
2	CytokinesIBA 01/2023 - 04/2013
2	perampanelIBA 01/2023 - 01/2020
2	GadoliniumIBA 11/2022 - 01/2022
2	AntibodiesIBA 11/2019 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 04/2013
2	Dopamine Receptors (Dopamine Receptor)IBA 12/2016 - 11/2010
2	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2016 - 02/2016
2	RotenoneIBA 02/2014 - 08/2008
2	Purinergic P1 Receptor AntagonistsIBA 02/2011 - 05/2009
2	Cholinergic Agents (Cholinergics)IBA 02/2011 - 05/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 03/2010 - 05/2006
2	Anticonvulsants (Antiepileptic Drugs)IBA 03/2010 - 05/2006
1	Cladribine FDA LinkGeneric 03/2024
1	Sphingosine-1-Phosphate ReceptorsIBA 02/2024
1	indole-3-carbaldehydeIBA 01/2024
1	LigandsIBA 01/2024
1	NeurograninIBA 04/2023
1	N 30IBA 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	Amino Acids FDA Link 01/2023
1	D-Aspartic Acid (D Aspartate)IBA 01/2023
1	Contrast MediaIBA 11/2022
1	ocrelizumabIBA 11/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2022
1	Natalizumab (Tysabri)FDA Link 09/2022
1	nitazoxanide (NTZ)FDA Link 09/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	ixekizumabIBA 12/2021
1	Interleukin-17 (Interleukin 17)IBA 12/2021
1	teriflunomideIBA 08/2021
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	nasIBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	AntioxidantsIBA 01/2020
1	N-acetylserotoninIBA 01/2020
1	AutoantibodiesIBA 11/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 11/2019
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 10/2018
1	Methylprednisolone FDA LinkGeneric 03/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Lacosamide FDA Link 01/2018

Therapy/Procedure

8	Therapeutics 11/2022 - 11/2006
1	Injections 05/2018